Is there a beneficial effect of the calcium channel blocker diltiazem on cyclosporine A nephrotoxicity in rats?

Experimental and Toxicologic Pathology

Volumn 50, Issue 4-6, 1998, Pages 484-490

  Kuhn U D ^a   Lupp, A ^a   Kostka, E ^b   Kuhl A ^c   Balogh, A ^a   Stein, G ^a   Fleck, Ch ^a  

^a Inst of Pharmacology and Toxicology   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^c JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

Calcium channel blocker; Cyclosporine A, nephrotoxicity; Diltiazem; Nephrotoxicity, cyclosporine A; Protective effect, calcium channel blocker

Indexed keywords

4 AMINOHIPPURIC ACID; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM ION; CYCLOSPORIN A; DILTIAZEM; GLUTATHIONE; HYDROGEN PEROXIDE; MAGNESIUM ION; POTASSIUM ION; SANDIMMUN OPTORAL; SODIUM ION; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG MIXTURE; FEMALE; GLOMERULUS FILTRATION RATE; INTRAPERITONEAL DRUG ADMINISTRATION; NEPHROTOXICITY; NONHUMAN; ORAL DRUG ADMINISTRATION; OXIDATIVE STRESS; RAT; URINE VOLUME;

EID: 0031658409     PISSN: 09402993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0940-2993(98)80038-9     Document Type: Article

References (32)

1. AITIO A A simple and sensitive assay of 7-ethoxycoumarin deethylation. Anal Biochem 1978; 85: 488-491.
2. BRADFORD MM A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye-binding. Anal Biochem 1976; 72: 248-254.
3. BRATTON AC, MARSHALL EK A new coupling component for sulfonamide determination. J Biol Chem 1939; 128: 537-550.
4. BROCKMÖLLER J, NEUMAYER HH, WAGNER K, et al. Pharmacokinetic interaction between cyclosporine and diltiazem. Eur J Clin Pharmac 1990; 38: 237-242.
5. BUEGE JKA, AusxSD Microsomal lipid peroxidation. Methods Enzymol 1978; 52: 302-310.
6. ELLMAN GL Tissue sulfhydryl groups. Arch Biochem Biophys 1958; 82: 70-77.
7. GILLUM DM, TRUONG L, TASBY J, et al. Chronic cyclosporine nephrotoxicity. A rodent model. Transplant 1988; 46: 285-292.
8. GöTZE S, AUCH-SCHWELK W, BOSSALLER C, et al. Preventive effects of diltiazem on cyclosporine A-induced vascular smooth muscle dysfunction. Transpl Int 1994; 7: 157-162.
9. HENRICSSON S, LINDHOLM A, ARAVOGLU M Cyclosporine metabolism in human liver microsomes and its inhibition by other drugs. Pharmac Toxicol 1990; 66: 49-52.
10. HILDEBRANDT AG, ROOTS I, TJOE M Hydrogen peroxide in hepatic microsomes. Methods Enzymol 1978; 52:342-350.
11. HISSIN PJ, HILF R A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal Biochem 1976; 74: 214-226.
12. KLINGER W, MÜLLER D Ethylmorphine-N-demetliylation by liver homogenate of newborn and adult rats; Enzyme kinetics and age course of Vmax and Km. Acta Biol Med Gerl977;36: 1149-1159.
13. KOLEVA M, STOYTCHEV T On the enzyme-inducing action of calcium antagonists. Arch Toxicol 1993; 67: 294-296.
14. KÜHN U, LUPP A, KOSTKA E, et al. The influence of diltiazem on cyclosporine A-levels and monooxygenase function in rats. Exp Toxic Pathol 1996; 48: Suppl II, 211-214.
15. KUNZENDORF U, WALZ G, BROCKMÖLLER J, et al. Influence of diltiazem on cyclosporine blood level. Klin Wochenschr 1987; 65: 1101-1103.
16. KUNZENDORF U, WALZ G, NEUMAYER HH, et al. Effects of diltiazem upon metabolism and immunosuppressive action of cyclosporine in kidney graft recipients. Transplant 1991; 52: 280-284.
17. Liu Z, MORTIMER O, SMITH ÇA, et al. Evidence for a role of cytochrome P450 2D6 and 3A4 in ethylmorphine metabolism. Br J Clin Pharmacol 1995; 39: 77-80.
18. MAENPAA J, RUSKOAHO H, PELKONEN O Inhibition of hepatic microsomal drug metabolism in rats by five calcium antagonists. Pharmacol Toxicol 1989; 64: 446-450.
19. MASON J Pharmacology of Cyclosporine (Sandimmun). VII. Pathophysiology and Toxicology of Cyclosporine in Humans and Animals. Pharmacol Rev 1989; 41:423-434.
20. MASON J The pathophysiology of Sandimmune (cyclosporine) in man and animals. PediatrNephrol 1990; 4:554-574.
21. MCNALLY PG, FEEHALLY J Pathophysiology of cyclosporin A nephrotoxicity: experimental and clinical observations. Nephrol Dial Transplant 1992; 7: 791-804.
22. MOVER TP, WINKELS J, KROM R, WIESNER R Evaluation of Abbott TDx monoclonal assay of cyclosporine in whole blood. Clin Chem 1991; 37: 1120-1121.
23. NAGAI Y Effect of cyclosporin on the thymus and spleen in rats. Nippon-Geka-Gakkai-Zasshi. 1988; 89: 906-920.
24. PICHARD L, GILLET G, FAHRE I, et al. Identification of the rabbit and human cytochromes P-450IIIA as the major enzymes involved in the N-demethylation of diltiazem. Drug Metab Dispos 1990a; 18: 711-719.
25. PICHARD L, FABRE I, FABRE G, et al. Cyclosporin A drug interactions. Screening for inducers and inhibitors of cytochrome P-450 (cyclosporin A oxidase) in primary cultures of human hepatocytes and in liver microsomes. Drug Metab Dispos 1990b; 18: 595-606.
26. POHL RJ, FOUTS JR A rapid method for assaying the metabolism of 7-ethoxyresorufin by microsomal subcellular fractions. Anal Biochem 1980; 107: 150-155.
27. RENTON KW Inhibition of hepatic microsomal drug metabolism by the calcium channel blockers diltiazem and verapamil. Biochem Pharmacol 1985; 34: 2549-2553.
28. SADRIEH N, THOMAS PE Characterization of rat cytochrome P450 isozymes involved in the covalent binding of cyclosporin A to microsomal proteins. Toxicol Appl Pharmacol 1994; 127: 222-232.
29. SKETRIS IS, METHOT ME, NICOL D, et al. Effect of calciumchannel blockers on cyclosporine clearance and use in renal transplant patients. Ann Pharmacother 1994;28:1227-1231.
30. SPERSCHNEIDER H, WAGNER C, KORN A, CHRISTIANS U Effect of diltiazem on concentration of cyclosporine metabolites in Sandimmune and Neoral treated kidney transplant patients. Med Klin 1997; 92: 589-596.
31. SOHTELL M, KARLMARK B, ULFENDAHL H FITC-inulin as a kidney tubule marker in the rat. Acta Physiol Scand 1983; 119:313-316
32. YAGI K Lipid peroxides and human diseases. Chem Phys Lipids 1987; 45: 337-351.